Sensus divinitatis

Sensus Healthcare to Participate in the Roth MKM 2023 Healthcare Opportunities Conference and the 43rd Annual Fall Clinical Dermatology Conference

Retrieved on: 
Monday, October 9, 2023

Sensus management will also participate in the 43rd Annual Fall Clinical Dermatology Conference being held October 19-22, 2023 at the Wynn Hotel in Las Vegas.

Key Points: 
  • Sensus management will also participate in the 43rd Annual Fall Clinical Dermatology Conference being held October 19-22, 2023 at the Wynn Hotel in Las Vegas.
  • Joe Sardano, chairman and chief executive officer of Sensus Healthcare, will deliver a 10-minute presentation at 11:15 a.m. Eastern time at the Yale Club.
  • To request a meeting with Sensus Healthcare management, please contact your Roth MKM representative or Kim Golodetz at LHA Investor Relations at [email protected] .
  • To schedule an appointment or for more information about Sensus Healthcare's participation, please contact Sensus Healthcare by visiting www.sensushealthcare.com .

Sensus Healthcare Sells Superficial Radiotherapy System to Cape Cod Hospital

Retrieved on: 
Thursday, September 28, 2023

BOCA RATON, Fla. , Sept. 28, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces the shipment of an SRT-100+™ System to Cape Cod Hospital in Hyannis, Massachusetts, the second SRT-100+ System sold to a hospital in Massachusetts.

Key Points: 
  • BOCA RATON, Fla. , Sept. 28, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces the shipment of an SRT-100+™ System to Cape Cod Hospital in Hyannis, Massachusetts, the second SRT-100+ System sold to a hospital in Massachusetts.
  • This sale represents the Company’s ongoing success in the U.S. Northeast region as treating skin cancer with Sensus SRT technology continues to draw interest from community hospital oncology departments.
  • Jeffrey Martin, M.D., a radiation oncologist at Cape Cod Hospital, said, “Non-melanoma skin cancers affect many patients we serve.
  • To schedule an appointment or for more information about Sensus Healthcare's participation, please contact Sensus Healthcare by visiting www.sensushealthcare.com.

Sensus Healthcare to Showcase its Full Line of Cutting-Edge Superficial Radiotherapy Devices for the Treatment of Non-melanoma Skin Cancer at ASTRO 2023 in San Diego

Retrieved on: 
Tuesday, September 26, 2023

Leveraging this esteemed event, Sensus Healthcare is set to present its full line of state-of-the-art superficial radiotherapy (SRT) devices for the treatment of non-melanoma skin cancer and keloids to hospital administrators and radiation oncologists from around the world.

Key Points: 
  • Leveraging this esteemed event, Sensus Healthcare is set to present its full line of state-of-the-art superficial radiotherapy (SRT) devices for the treatment of non-melanoma skin cancer and keloids to hospital administrators and radiation oncologists from around the world.
  • ASTRO is the premier gathering of radiation oncology professionals, where industry leaders converge to discuss breakthrough technologies and cutting-edge treatment methodologies.
  • Sensus Healthcare's devices utilize the Multi-Dimensional Superficial Radiotherapy platform, which provides an alternative low-energy X-ray treatment for various types of non-melanoma skin cancer and keloids.
  • To schedule an appointment or for more information about Sensus Healthcare's participation, please contact Sensus Healthcare by visiting www.sensushealthcare.com.